Central Nervous System Diseases  >>  crenezumab (RG7412)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenezumab (RG7412) / AC Immune
NCT00736775: A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

Completed
1
56
US
anti-Abeta, placebo
Genentech, Inc.
Alzheimer's Disease
05/10
 

Download Options